Parag Goyal1,2, Joanna Bryan2, Jerard Kneifati-Hayek2, Madeline R Sterling2, Samprit Banerjee3, Mathew S Maurer4, Mark S Lachs5, Monika M Safford2. 1. Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, New York. 2. Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York. 3. Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York. 4. Center for Advanced Cardiac Care, Columbia University Medical Center, New York, New York. 5. Division of Geriatrics, Department of Medicine, Weill Cornell Medical College, New York, New York.
Abstract
OBJECTIVES: To determine whether the number of medications taken by adults with heart failure (HF) and impairment in activities of daily living (ADL)-a subpopulation in whom the risks of a high medication burden may outweigh the benefits-differs from the number taken by those without impairment in ADLs. DESIGN: Cross-sectional. SETTING: National Health and Nutrition Examination Survey (NHANES; 2003-2014), a cross-sectional survey that produces national estimates of adults in the United States. PARTICIPANTS: Adults aged 50 and older (mean 70) with self-reported HF (N= 947; representing 4.6 million adults with HF in the United States. MEASURMENTS: We assessed ADL impairment and medication count based on self-report. ADL impairment was defined as having difficulty with or being unable to dress, feed oneself, or get in and out of bed. To determine the independent association between ADL impairment and medication count, we performed sequential Poisson multivariable regression analyses. All analyses were cross-sectional in nature and accounted for the complex survey design of NHANES. RESULTS: Mean medication count was 7.2, and 74% of participants were taking 5 or more medications (polypharmacy). In a multivariable model, ADL impairment was not independently associated with medication count. These findings were similar for those with 3 or more hospitalizations in the prior year, declining health status, and cognitive impairment. CONCLUSION: After adjusting for confounders including comorbidity, we found that adults with HF and ADL impairment take as many medications as those without ADL impairment. This suggests that providers may not sufficiently consider functional impairment when prescribing medications to adults with HF and thus may unnecessarily expose individuals to risk of adverse outcomes. J Am Geriatr Soc 67:284-291, 2019.
OBJECTIVES: To determine whether the number of medications taken by adults with heart failure (HF) and impairment in activities of daily living (ADL)-a subpopulation in whom the risks of a high medication burden may outweigh the benefits-differs from the number taken by those without impairment in ADLs. DESIGN: Cross-sectional. SETTING: National Health and Nutrition Examination Survey (NHANES; 2003-2014), a cross-sectional survey that produces national estimates of adults in the United States. PARTICIPANTS: Adults aged 50 and older (mean 70) with self-reported HF (N= 947; representing 4.6 million adults with HF in the United States. MEASURMENTS: We assessed ADL impairment and medication count based on self-report. ADL impairment was defined as having difficulty with or being unable to dress, feed oneself, or get in and out of bed. To determine the independent association between ADL impairment and medication count, we performed sequential Poisson multivariable regression analyses. All analyses were cross-sectional in nature and accounted for the complex survey design of NHANES. RESULTS: Mean medication count was 7.2, and 74% of participants were taking 5 or more medications (polypharmacy). In a multivariable model, ADL impairment was not independently associated with medication count. These findings were similar for those with 3 or more hospitalizations in the prior year, declining health status, and cognitive impairment. CONCLUSION: After adjusting for confounders including comorbidity, we found that adults with HF and ADL impairment take as many medications as those without ADL impairment. This suggests that providers may not sufficiently consider functional impairment when prescribing medications to adults with HF and thus may unnecessarily expose individuals to risk of adverse outcomes. J Am Geriatr Soc 67:284-291, 2019.
Authors: Tanya R Gure; Ryan J McCammon; Christine T Cigolle; Todd M Koelling; Caroline S Blaum; Kenneth M Langa Journal: Circ Cardiovasc Qual Outcomes Date: 2012-05
Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff Journal: Circulation Date: 2013-06-05 Impact factor: 29.690
Authors: Antonio Cherubini; Joaquim Oristrell; Xavier Pla; Carmelinda Ruggiero; Roberta Ferretti; Germán Diestre; A Mark Clarfield; Peter Crome; Cees Hertogh; Vita Lesauskaite; Gabriel-Ioan Prada; Katarzyna Szczerbinska; Eva Topinkova; Judith Sinclair-Cohen; David Edbrooke; Gary H Mills Journal: Arch Intern Med Date: 2011-03-28
Authors: Nadine Shehab; Maribeth C Lovegrove; Andrew I Geller; Kathleen O Rose; Nina J Weidle; Daniel S Budnitz Journal: JAMA Date: 2016-11-22 Impact factor: 56.272
Authors: Zachary A Marcum; Megan E Amuan; Joseph T Hanlon; Sherrie L Aspinall; Steven M Handler; Christine M Ruby; Mary Jo V Pugh Journal: J Am Geriatr Soc Date: 2011-12-08 Impact factor: 5.562
Authors: Dima M Qato; G Caleb Alexander; Rena M Conti; Michael Johnson; Phil Schumm; Stacy Tessler Lindau Journal: JAMA Date: 2008-12-24 Impact factor: 56.272
Authors: Ashok Krishnaswami; Michael A Steinman; Parag Goyal; Andrew R Zullo; Timothy S Anderson; Kim K Birtcher; Sarah J Goodlin; Mathew S Maurer; Karen P Alexander; Michael W Rich; Jennifer Tjia Journal: J Am Coll Cardiol Date: 2019-05-28 Impact factor: 24.094
Authors: Matthew T Mefford; Alysse Sephel; Melissa K Van Dyke; Ligong Chen; Raegan W Durant; Todd M Brown; Matthew Fifolt; Juan Maya; Parag Goyal; Monika M Safford; Emily B Levitan Journal: Am J Cardiol Date: 2019-02-23 Impact factor: 2.778
Authors: Madeline R Sterling; Joanna Bryan Ringel; Laura C Pinheiro; Monika M Safford; Emily B Levitan; Erica Phillips; Todd M Brown; Oanh K Nguyen; Parag Goyal Journal: Circ Heart Fail Date: 2021-12-06 Impact factor: 8.790
Authors: Lina M Brinker; Matthew C Konerman; Pedram Navid; Michael P Dorsch; Jennifer McNamara; Cristen J Willer; Mary E Tinetti; Scott L Hummel; Parag Goyal Journal: Am J Med Date: 2020-08-18 Impact factor: 4.965
Authors: Lauren Gilstrap; Andrea M Austin; Barbara Gladders; Parag Goyal; A James O'Malley; Amber Barnato; Anna N A Tosteson; Jonathan S Skinner Journal: J Am Geriatr Soc Date: 2021-06-15 Impact factor: 7.538